secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0001213900-23-056618
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital extends business combination deadline to Oct 11, 2023 with $825K convertible note to FutureTech Capital
--------------------------------------------------------------------------------

- Deposited $825,000 into trust account to extend deadline by three months from July 11 to October 11, 2023.
- Issued convertible promissory note for $825,000 to FutureTech Capital LLC; convertible into Class A shares at $10 per share upon business combination.
- Interest at lowest short-term Applicable Federal Rate; note matures upon business combination or liquidation.
- This is the second of two permissible three-month extensions under the company's governing documents.
- If no business combination, note will be repaid only from funds outside trust account or forfeited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390023056618/0001213900-23-056618-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390023056618/ea181625-8k425_denalicap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-056618

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer